BRAF and melanoma: ,2,3 About half of all melanomas present with a gain-of-function mutation in the mitogen-activated protein kinase (MAPK) / extracellular signal-regulated kinase (ERK) pathway, specifically in the kinase BRAF, promoting proliferation and survival.4